<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35768406</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8978</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Psychological medicine</Title><ISOAbbreviation>Psychol Med</ISOAbbreviation></Journal><ArticleTitle>Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials.</ArticleTitle><Pagination><StartPage>2426</StartPage><EndPage>2440</EndPage><MedlinePgn>2426-2440</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1017/S0033291722002203</ELocationID><Abstract><AbstractText Label="BACKGROUND">Among patients diagnosed with COVID-19, a substantial proportion are experiencing ongoing symptoms for months after infection, known as 'long COVID'. Long COVID is associated with a wide range of physical and neuropsychological symptoms, including impacts on mental health, cognition, and psychological wellbeing. However, intervention research is only beginning to emerge. This systematic review synthesizes currently registered trials examining interventions for mental health, cognition, and psychological wellbeing in patients with long COVID.</AbstractText><AbstractText Label="METHODS">Standard systematic review guidelines were followed. Trials registered in two large trial registries in 2020 to May 2022 were reviewed. Included studies were narratively synthesized by type of intervention and a risk-of-bias assessment was conducted.</AbstractText><AbstractText Label="RESULTS">Forty-two registered trials were included, with a total target sample size of 5814 participants. These include 11 psychological interventions, five pharmacological and other medical interventions, and five evaluating herbal, nutritional, or natural supplement interventions. An additional nine trials are examining cognitive and neurorehabilitation interventions and 12 are examining physiotherapy or physical rehabilitation. Most trials are randomized, but many are feasibility trials; trials are evaluating a wide spectrum of outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">While there is a newly emerging body of research testing interventions for mental health, cognition, and psychological wellbeing in long COVID, the breadth and scope of the research remains limited. It is urgently incumbent on researchers to expand upon the intervention research currently under way, in order to generate high-quality evidence on a wide range of candidate interventions for diverse long COVID patient populations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hawke</LastName><ForeName>Lisa D</ForeName><Initials>LD</Initials><Identifier Source="ORCID">0000-0003-1108-9453</Identifier><AffiliationInfo><Affiliation>Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Anh T P</ForeName><Initials>ATP</Initials><AffiliationInfo><Affiliation>Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ski</LastName><ForeName>Chantal F</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0003-1324-2933</Identifier><AffiliationInfo><Affiliation>Integrated Care Academy, University of Suffolk, Ipswich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>David R</ForeName><Initials>DR</Initials><Identifier Source="ORCID">0000-0001-8518-6307</Identifier><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Clement</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8188-9600</Identifier><AffiliationInfo><Affiliation>Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castle</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3075-1580</Identifier><AffiliationInfo><Affiliation>Centre for Complex Interventions, Centre for Addiction and Mental Health, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>WI1-179893</GrantID><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Psychol Med</MedlineTA><NlmUniqueID>1254142</NlmUniqueID><ISSNLinking>0033-2917</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="Y">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">psychosocial interventions</Keyword><Keyword MajorTopicYN="N">systematic review protocol</Keyword><Keyword MajorTopicYN="N">wellbeing</Keyword></KeywordList><CoiStatement>David Castle has received grant monies for research from Servier, Boehringer Ingelheim; Travel Support and Honoraria for Talks and Consultancy from Servier, Seqirus, Lundbeck. He is a founder of the Optimal Health Program (OHP), and holds 50% of the IP for OHP; and is part owner of Clarity Healthcare. He does not knowingly have stocks or shares in any pharmaceutical company. Other authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35768406</ArticleId><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="doi">10.1017/S0033291722002203</ArticleId><ArticleId IdType="pii">S0033291722002203</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acart&#xfc;rk, C., &amp; &#xd6;zt&#xfc;rk, T. (2021). Culturally adapted cognitive behavioral intervention to reduce psychological distress among COVID-19 survivors: A randomized controlled trial. Retrieved from https://ClinicalTrials.gov/show/NCT04949061.</Citation></Reference><Reference><Citation>Aiyegbusi, O. L., Hughes, S. E., Turner, G., Rivera, S. C., McMullan, C., Chandan, J. S., &#x2026; Calvert, M. J. (2021). Symptoms, complications and management of long COVID: A review. Journal of the Royal Society of Medicine, 114(9), 428&#x2013;442. doi:10.1177/01410768211032850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Aknin, L. B., Neve, J. E. D., Dunn, E. W., Fancourt, D., Goldberg, E., Helliwell, J., &#x2026; Amor, Y. B. (2022). Mental health during the first year of the COVID-19 pandemic: A review and recommendations for moving forward. Perspectives on Psychological Science, 1&#x2013;22. doi:10.1177/17456916211029964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17456916211029964</ArticleId><ArticleId IdType="pmc">PMC9274782</ArticleId><ArticleId IdType="pubmed">35044275</ArticleId></ArticleIdList></Reference><Reference><Citation>Alderman, S. E., Montemayor, M., &amp; Savitz, S. (2022). Post-acute COVID-19, inflammation, and depression. Retrieved from https://ClinicalTrials.gov/show/NCT05346120.</Citation></Reference><Reference><Citation>Allemang, B., Sitter, K., &amp; Dimitropoulos, G. (2022). Pragmatism as a paradigm for patient-oriented research. Health Expectations, 25(1) 38&#x2013;47. doi:10.1111/hex.13384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.13384</ArticleId><ArticleId IdType="pmc">PMC8849373</ArticleId><ArticleId IdType="pubmed">34748689</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan, N. A. (2021). The road to addressing long COVID. Science, 373(6554), 491&#x2013;493. doi:10.1126/science.abg7113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abg7113</ArticleId><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson, C., &amp; Carcel, C. (2021). An international, investigator initiated and conducted, pragmatic clinical trial to determine whether 40mg Atorvastatin daily can improve neurocognitive function in adults with long COVID neurological symptoms. Retrieved from https://ClinicalTrials.gov/show/NCT04904536.</Citation></Reference><Reference><Citation>Asimakos, A., &amp; Katsaounou, P. (2021). Implementing a rehabilitation program in patients recovering from COVID-19 infection. Retrieved from https://ClinicalTrials.gov/show/NCT04935437.</Citation></Reference><Reference><Citation>Bileviciute-Ljungar, I., &amp; Borg, K. (2021). Internet-based multidisciplinary rehabilitation for longterm COVID-19 syndrome. Retrieved from https://ClinicalTrials.gov/show/NCT04961333.</Citation></Reference><Reference><Citation>Blane, D., Combet, E., &amp; the ReDIRECT Study Team. (2021). Remote diet intervention to reduce long COVID symptoms trial. Retrieved from https://www.isrctn.com/ISRCTN12595520.</Citation></Reference><Reference><Citation>Bl&#xe1;zquez, B. O. (2022). Effectiveness and cost-effectiveness of a multimodal programme as coadjuvant treatment in people with a diagnosis of long COVID-19 from primary health care: A randomised clinical trial. Retrieved from https://www.isrctn.com/ISRCTN91104012.</Citation></Reference><Reference><Citation>Brown, D. A., &amp; O'Brien, K. K. (2021). Conceptualising long COVID as an episodic health condition. BMJ Global Health, 6(9), 007&#x2013;004. doi:10.1136/bmjgh-2021-007004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-007004</ArticleId><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xfc;ssow, H., &amp; Timmis, K. (2021). COVID-19: Long covid and its societal consequences. Environmental Microbiology, 23(8), 4077&#x2013;4091. doi: 10.1111/1462-2920.15634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.15634</ArticleId><ArticleId IdType="pubmed">34110078</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse, M., &amp; Potter, C. (2022). Effectiveness and cost-effectiveness of a personalised self-management support intervention for non-hospitalised people living with long COVID. Retrieved from https://www.isrctn.com/ISRCTN36407216.</Citation></Reference><Reference><Citation>Cabrera Martimbianco, A. L., Pacheco, R. L., Bagattini, &#xc2;. M., &amp; Riera, R. (2021). Frequency, signs and symptoms, and criteria adopted for long COVID: A systematic review. International Journal of Clinical Practice, 75, e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard, F., &amp; Perego, E. (2021). How and why patients made long Covid. Social Science &amp; Medicine, 268, 113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Canadian Institutes of Health Research. (2019). Strategy for patient-oriented research &#x2013; Patient engagement framework. Retrieved from https://cihr-irsc.gc.ca/e/48413.html.</Citation></Reference><Reference><Citation>Chantal, S., Hiyam, A., &amp; Karen, W. (2021). Long COVID Optimal Health Program (LC-OHP) to enhance psychological and physical health: A feasibility randomised controlled trial. Retrieved from https://www.isrctn.com/ISRCTN38746119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9106280</ArticleId><ArticleId IdType="pubmed">35468586</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., &amp; Mukherjee, B. (2022). Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. The Journal of Infectious Diseases. Advance online publication. 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Collette, F., Willems, S., Cabello, C., &amp; Lesoinne, A. (2022). Immediate and long term cognitive improvement after cognitive versus emotion management psychoeducation programs: A randomised trial in Covid patients with neuropsychological difficulties. Retrieved from https://ClinicalTrials.gov/show/NCT05167266.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10436391</ArticleId><ArticleId IdType="pubmed">37596541</ArticleId></ArticleIdList></Reference><Reference><Citation>Croghan, I., Hurt, R. T., Fokken, S., &amp; Currie, G. (2022). The benefit of mindfulness-based intervention using a wearable wellness brain sensing device (Muse-S) in the treatment of post-Covid symptoms. Retrieved from https://clinicaltrials.gov/show/NCT05199233.</Citation></Reference><Reference><Citation>Crook, H., Raza, S., Nowell, J., Young, M., &amp; Edison, P. (2021). Long covid &#x2013; Mechanisms, risk factors, and management. BMJ, 374, n1648. doi:10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Culos-Reed, N., &amp; Twomey, R. (2021). BREATHE: A mixed-methods evaluation of a virtual self-management program for people living with long COVID-19 in Alberta. Retrieved from https://clinicaltrials.gov/show/NCT05107440.</Citation></Reference><Reference><Citation>Edgell, H. (2022). Inspiratory muscle training in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and COVID-19 survivors. Retrieved from https://ClinicalTrials.gov/show/NCT05196529.</Citation></Reference><Reference><Citation>Eryilmaz, H., Andreou, B., &amp; Pax, M. (2021). Home-based transcranial direct current stimulation (tDCS) for treatment of cognitive post-acute sequelae of COVID-19 (PASC). Retrieved from https://clinicaltrials.gov/show/NCT05092516.</Citation></Reference><Reference><Citation>Ferrier, L., Ski, C. F., O'Brien, C., Jenkins, Z., Thompson, D. R., Moore, G., &#x2026; Castle, D. J. (2021). Bridging the gap between diabetes care and mental health: Perspectives of the Mental health IN DiabeteS Optimal Health Program (MINDS OHP). BMC Endocrine Disorders, 21(1), 96. doi: 10.1186/s12902-021-00760-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12902-021-00760-3</ArticleId><ArticleId IdType="pmc">PMC8105945</ArticleId><ArticleId IdType="pubmed">33964904</ArticleId></ArticleIdList></Reference><Reference><Citation>Fl&#xf6;el, A. (2021). Neuromodulation through brain stimulation-assisted cognitive training in patients with post-COVID19 cognitive impairment. Retrieved from https://ClinicalTrials.gov/show/NCT04944147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002255</ArticleId><ArticleId IdType="pubmed">35410927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, Y., Zhong, L. L. D., Quach, B., Davies, B., Ash, G. I., Lin, Z. X., &#x2026; Baker, J. S. (2020). Would cardiorespiratory exercise and Chinese herbal medicine facilitate rehabilitation among post-discharge patients with COVID-19? Clinical efficacy and mechanisms. Retrieved from https://clinicaltrials.gov/show/NCT04572360.</Citation></Reference><Reference><Citation>Gao, Y., Zhong, L. L. D., Quach, B., Davies, B., Ash, G. I., Lin, Z. X., &#x2026; Baker, J. S. (2021). COVID-19 rehabilitation with herbal medicine and cardiorespiratory exercise: Protocol for a clinical study. JMIR Research Protocols, 10(5), e25556. doi:10.2196/25556.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/25556</ArticleId><ArticleId IdType="pmc">PMC8158531</ArticleId><ArticleId IdType="pubmed">33970864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard, C. E., S&#xfc;tsch, C., Bengs, S., Deforth, M., Buehler, K. P., Hamouda, N., &#x2026; Gebhard, C. (2021). Sex- and gender-specific risk factors of post-COVID-19 syndrome: A population-based cohort study in Switzerland. medRxiv, 2021.2006.2030.21259757. doi:10.1101/2021.06.30.21259757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.30.21259757</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert, M. M., Chamberlain, J. A., White, C. R., Mayers, P. W., Pawsey, B., Liew, D., &#x2026; Castle, D. J. (2012). Controlled clinical trial of a self-management program for people with mental illness in an adult mental health service &#x2013; The Optimal Health Program (OHP). Australian Health Review, 36(1), 1&#x2013;7. doi: 10.1071/AH11008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1071/AH11008</ArticleId><ArticleId IdType="pubmed">22513012</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilliland, T., &amp; Driver, S. (2022). Exercise training and functional, cognitive, and emotional well-being in adults with post-acute sequelae of SARS-CoV-2 (COVID-19) infection (PASC): A randomized controlled trial. Retrieved from https://ClinicalTrials.gov/show/NCT05218174.</Citation></Reference><Reference><Citation>Glezer, S. (2022). Portable oxygen concentrator (POC) versus standard of care in patients with long-COVID cognitive impairment: A randomized crossover exploratory pilot study. Retrieved from https://clinicaltrials.gov/show/NCT05212831.</Citation></Reference><Reference><Citation>Greenspan, N., Walsh-Messinger, J., Mackles, M., Debidda, M., Kaner, R., DePalo, L., &#x2026; Chin, W. (2021). Cardiopulmonary rehabilitation in COVID-19 longhaulers. Retrieved from https://ClinicalTrials.gov/show/NCT04898205.</Citation></Reference><Reference><Citation>Gunning, F., Oberlin, L. E., &amp; Victoria, L. (2021). Improving cognitive health in COVID-19 survivors through digital therapeutics. Retrieved from https://ClinicalTrials.gov/show/NCT04843930.</Citation></Reference><Reference><Citation>Guzman-Velez, E., Guti&#xe9;rrez-Mart&#xed;nez, L., Gonz&#xe1;lez-Irizarry, G. J., &amp; Gerber, J. A. (2021). Randomized, placebo-controlled parallel group clinical trial of Nicotinamide Riboside to evaluate NAD + levels in individuals with persistent cognitive and physical symptoms after COVID-19 illness (&#x2018;long-COVID&#x2019;). Retrieved from https://clinicaltrials.gov/show/NCT04809974.</Citation></Reference><Reference><Citation>H&#xe5;kansson, A. C., Hartman, K., &amp; Cronhjort, M. (2021). Detection and treatment of long-term symptoms post-COVID syndrome in patients who have been treated in intensive care for COVID-19. Retrieved from https://clinicaltrials.gov/show/NCT05119608.</Citation></Reference><Reference><Citation>Hamilton, C. B., Hoens, A. M., Backman, C. L., McKinnon, A. M., McQuitty, S., English, K., &#x2026; Li, L. C. (2018). An empirically based conceptual framework for fostering meaningful patient engagement in research. Health Expectations, 21(1), 396&#x2013;406. doi: 10.1111/hex.12635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hex.12635</ArticleId><ArticleId IdType="pmc">PMC5750689</ArticleId><ArticleId IdType="pubmed">28984405</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher, S., Ward, B., &amp; Edgar, N. (2021). Enhancing COVID rehabilitation with technology (ECORT): An open-label, single site randomized controlled trial evaluating the effectiveness of electronic case management for Individuals with persistent COVID-19 symptoms. Retrieved from https://ClinicalTrials.gov/show/NCT05019963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9437413</ArticleId><ArticleId IdType="pubmed">36056372</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinsch, M., Wells, H., Sampson, D., Wootten, A., Cupples, M., Sutton, C., &#x2026; Kay-Lambkin, F. (2022). Protective factors for mental and psychological wellbeing in Australian adults: A review. Mental Health and Prevention. 25, 200192. doi: 10.1016/j.mhp.2020.200192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mhp.2020.200192</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins, J. P. T., Savovi&#x107;, J., Page, M. J., Elbers, R. G., &amp; Sterne, J. A. C. (2021). Chapter 8: Assessing risk of bias in a randomized trial. In Thomas J., Higgins J. P. T., Chandler J., Cumpston M., Li T., Page M. J., Welch V. A. (Eds.), Cochrane handbook for systematic reviews of interventions (6.2nd ed.). Cochrane. Accessed at: https://training.cochrane.org/handbook/current/chapter-08.</Citation></Reference><Reference><Citation>Hoare, E., Milton, K., Foster, C., &amp; Allender, S. (2016). The associations between sedentary behaviour and mental health among adolescents: A systematic review. The International Journal of Behavioral Nutrition and Physical Activity, 13(1), 108. doi:10.1186/s12966-016-0432-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12966-016-0432-4</ArticleId><ArticleId IdType="pmc">PMC5055671</ArticleId><ArticleId IdType="pubmed">27717387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer, C., Ebert, A., Szabo, K., Platten, M., Meyer-Lindenberg, A., &amp; Kranaster, L. (2021). Decreased utilization of mental health emergency service during the COVID-19 pandemic. European Archives of Psychiatry and Clinical Neuroscience, 271(2), 377&#x2013;379. doi:10.1007/s00406-020-01151-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-020-01151-w</ArticleId><ArticleId IdType="pmc">PMC7282463</ArticleId><ArticleId IdType="pubmed">32519205</ArticleId></ArticleIdList></Reference><Reference><Citation>International Foundation of Integrated Care. (2020). Realising the true value of integrated care: beyond COVID-19. Retrieved from https://integratedcarefoundation.org/publications/realising-the-true-value-of-integrated-care-beyond-covid-19-2.</Citation></Reference><Reference><Citation>Iveson, E., Lynskey, M., &amp; Thurgur, H. (2021). Safety and tolerability of full spectrum cannabidiol dominant medicinal cannabis in treating symptoms associated with Long COVID: A feasibility study. Retrieved from https://clinicaltrials.gov/show/NCT04997395.</Citation></Reference><Reference><Citation>Janiaud, P., Hemkens, L. G., &amp; Ioannidis, J. P. A. (2021). Challenges and lessons learned from COVID-19 trials: Should we be doing clinical trials differently? Canadian Journal of Cardiology, 37(9), 1353&#x2013;1364. doi: 10.1016/j.cjca.2021.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2021.05.009</ArticleId><ArticleId IdType="pmc">PMC8164884</ArticleId><ArticleId IdType="pubmed">34077789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins, E. K., McAuliffe, C., Hirani, S., Richardson, C., Thomson, K. C., McGuinness, L., &#x2026; Gadermann, A. (2021a). A portrait of the early and differential mental health impacts of the COVID-19 pandemic in Canada: Findings from the first wave of a nationally representative cross-sectional survey. Preventive Medicine, 145, 106333. doi: 10.1016/j.ypmed.2020.106333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2020.106333</ArticleId><ArticleId IdType="pmc">PMC9755654</ArticleId><ArticleId IdType="pubmed">33509605</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins, Z. M., Tan, E. J., O'Flaherty, E., Knowles, S., Thompson, D. R., Ski, C. F., &#x2026; Gock, H. (2021b). A psychosocial intervention for individuals with advanced chronic kidney disease: A feasibility randomized controlled trial. Nephrology, 26(5), 442&#x2013;453. doi: 10.1111/nep.13850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.13850</ArticleId><ArticleId IdType="pubmed">33484221</ArticleId></ArticleIdList></Reference><Reference><Citation>Karosanidze, I., &amp; Panossian, A. (2021). Effect of ADAPT232 supplementation on recovery of patients in rehabilitation period in long COVID-19: A randomized, double-blind, placebo-controlled trial. Retrieved from https://clinicaltrials.gov/show/NCT04795557.</Citation></Reference><Reference><Citation>Koczulla, A. R., &amp; Gloeckl, R. (2022). Symptom-based rehabilitation compared to usual care in Post-COVID: A randomized controlled trial. Retrieved from https://ClinicalTrials.gov/show/NCT05172206.</Citation></Reference><Reference><Citation>Koczulla, A. R., &amp; Schneeberger, T. (2021). Effects of cranial electrotherapy stimulation on anxiety of patients after COVID-19: A randomised controlled pilot study. Retrieved from https://ClinicalTrials.gov/show/NCT05126511.</Citation></Reference><Reference><Citation>Lai, H. M. X., Cleary, M., Sitharthan, T., &amp; Hunt, G. E. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990&#x2013;2014: A systematic review and meta-analysis. Drug and Alcohol Dependence, 154, 1&#x2013;13. doi: 10.1016/j.drugalcdep.2015.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2015.05.031</ArticleId><ArticleId IdType="pubmed">26072219</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, K., Bacchetti, P., &amp; Sim, I. (2008). Publication of clinical trials supporting successful new drug applications: A literature analysis. PLoS Medicine, 5(9), e191. doi:10.1371/journal.pmed.0050191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050191</ArticleId><ArticleId IdType="pmc">PMC2553819</ArticleId><ArticleId IdType="pubmed">18816163</ArticleId></ArticleIdList></Reference><Reference><Citation>Liira, H., &amp; Arokoski, J. (2022). Amygdala and Insula Retraining (AIR) program and HUS Internet therapy compared to treatment as usual in Bodily Stress Syndrome, Fibromyalgia, Post Covid-19, and Chronic Fatigue Syndrome (ME/CFS). Retrieved from https://clinicaltrials.gov/show/NCT05212467.</Citation></Reference><Reference><Citation>Liu, B., Jayasundara, D., Pye, V., Dobbins, T., Dore, G. J., Matthews, G., &#x2026; Spokes, P. (2021a). Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. The Lancet Regional Health &#x2013; Western Pacific, 12. doi:10.1016/j.lanwpc.2021.100193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2021.100193</ArticleId><ArticleId IdType="pmc">PMC8225991</ArticleId><ArticleId IdType="pubmed">34189493</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J., Nie, H., Li, S., Chen, X., Cao, H., Ren, J., &#x2026; Xia, F. (2021b). Tracing the pace of COVID-19 research: Topic modeling and evolution. Big Data Research, 25, 100236, 1-10. doi: 10.1016/j.bdr.2021.100236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bdr.2021.100236</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, P., Patel, K., Pinto, C., Jaiswal, R., Tirupathi, R., Pillai, S., &#x2026; Patel, U. (2022). Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL) &#x2013; A systematic review and meta-analysis. Journal of Medical Virology, 94(1), 253&#x2013;262. doi: 10.1002/jmv.27309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann, D. M., Chen, J., Chunara, R., Testa, P. A., &amp; Nov, O. (2020). COVID-19 transforms health care through telemedicine: Evidence from the field. Journal of the American Medical Informatics Association, 27(7), 1132&#x2013;1135. doi:10.1093/jamia/ocaa072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocaa072</ArticleId><ArticleId IdType="pmc">PMC7188161</ArticleId><ArticleId IdType="pubmed">32324855</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, L., Bibby, J., &amp; Abbs, I. (2020). Emerging evidence on COVID-19's impact on mental health and health inequalities. Retrieved from https://www.health.org.uk/news-and-comment/blogs/emerging-evidence-on-covid-19s-impact-on-mental-health-and-health.</Citation></Reference><Reference><Citation>Martin, F., &amp; Lynall, A. (2022). Are there improvements in mental wellbeing following a digital peer-supported self-management intervention versus a wait-list control group, for people living with long COVID? A non-randomised pre-post pilot study. Retrieved from https://www.isrctn.com/ISRCTN11868601.</Citation></Reference><Reference><Citation>Maury, A., Lyoubi, A., Peiffer-Smadja, N., de Broucker, T., &amp; Meppiel, E. (2020). Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Revue neurologique, 177(1&#x2013;2), 51&#x2013;64. doi: 10.1016/j.neurol.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurol.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7832485</ArticleId><ArticleId IdType="pubmed">33446327</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntyre, R. S., &amp; Subramaniapillai, M. (2021). Randomized, double-blinded, placebo-controlled study evaluating Vortioxetine for cognitive deficits in persons with Post-COVID-19 syndrome. Retrieved from https://clinicaltrials.gov/show/NCT05047952.</Citation></Reference><Reference><Citation>Melamed, I., Collins, M., &amp; Palm, A. (2021). A randomized, double blind, placebo controlled, cross-over, proof-of-concept study to evaluate the benefit of RUCONEST&#xae; (C1 Esterase Inhibitor [Recombinant]) in improving neurological symptoms in Post-SARS-CoV-2 infection. Retrieved from https://clinicaltrials.gov/show/NCT04705831.</Citation></Reference><Reference><Citation>Mlinaric, A., Horvat, M., &amp; Supak Smolcic, V. (2017). Dealing with the positive publication bias: Why you should really publish your negative results. Biochemia Medica, 27(3), 030201. doi:10.11613/BM.2017.030201.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2017.030201</ArticleId><ArticleId IdType="pmc">PMC5696751</ArticleId><ArticleId IdType="pubmed">29180912</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafao&#x11f;lu, R., &amp; Yasac&#x131;, Z. (2022). Short term outcomes of tele-rehabilitation in patients with post-Covid syndrome. Retrieved from https://ClinicalTrials.gov/show/NCT05381675.</Citation></Reference><Reference><Citation>National Collaborating Centre for Mental Health. (2010). Depression in adults with a chronic physical health problem: treatment and management. In NICE Clinical Guidelines, No. 91. Leicester (UK): British Psychological Society.</Citation><ArticleIdList><ArticleId IdType="pubmed">22259826</ArticleId></ArticleIdList></Reference><Reference><Citation>Neri, E. S., &amp; Barcessat, A. R. P. (2021). REAC technology protocols in post-Covid-19 syndrome (PC-19-S): Randomized clinical study. Retrieved from https://ensaiosclinicos.gov.br/rg/RBR-77jbq56.</Citation></Reference><Reference><Citation>Nogueira, P. A. D. M. S., Silva, G. A., &amp; Nogueira, P. (2021). Efficacy of home inspiratory muscle training in post-COVID-19 patients: A randomized clinical trial. Retrieved from https://clinicaltrials.gov/show/NCT05077241.</Citation></Reference><Reference><Citation>Ownby, R. L., &amp; Davenport, R. (2022). An open-label trial of computer-delivered cognitive training in persons with post-acute COVID-19 syndrome. Retrieved from https://ClinicalTrials.gov/show/NCT05338749.</Citation></Reference><Reference><Citation>Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., &#x2026; Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran, A. V., Jayadevan, R., &amp; Sashidharan, S. (2021). Long COVID: An overview. Diabetes &amp; Metabolic Syndrome, 15(3), 869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice, E., &amp; Jacobs, J. (2021). Homeopathic treatment of post-acute COVID-19 syndrome: A pilot randomized controlled trial. Retrieved from https://clinicaltrials.gov/show/NCT05104749.</Citation></Reference><Reference><Citation>Richardson, W. S., Wilson, M. C., Nishikawa, J., &amp; Hayward, R. S. (1995). The well-built clinical question: A key to evidence-based decisions. ACP Journal Club, 123(3), A12&#x2013;A13.</Citation><ArticleIdList><ArticleId IdType="pubmed">7582737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ramirez, D. C. (2021). Pulmonary rehabilitation post-COVID-19: A pilot study. Retrieved from https://ClinicalTrials.gov/show/NCT05003271.</Citation></Reference><Reference><Citation>Silva, M., Loureiro, A., &amp; Cardoso, G. (2016). Social determinants of mental health: A review of the evidence. The European Journal of Psychiatry, 30(4), 259&#x2013;292. Retrieved from http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0213-61632016000400004&amp;nrm=iso.</Citation></Reference><Reference><Citation>Sim, J., &amp; Wright, C. C. (2005). The Kappa statistic in reliability studies: Use, interpretation, and sample size requirements. Physical Therapy, 85(3), 257&#x2013;268. doi:10.1093/ptj/85.3.257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/85.3.257</ArticleId><ArticleId IdType="pubmed">15733050</ArticleId></ArticleIdList></Reference><Reference><Citation>Skivington, K., Matthews, L., Simpson, S. A., Craig, P., Baird, J., Blazeby, J. M., &#x2026; Moore, L. (2021). A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. BMJ, 374, n2061. doi:10.1136/bmj.n2061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n2061</ArticleId><ArticleId IdType="pmc">PMC8482308</ArticleId><ArticleId IdType="pubmed">34593508</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam, B. (2021). Yogic breathing and guided meditation for long COVID symptoms. Retrieved from https://clinicaltrials.gov/show/NCT05139979.</Citation></Reference><Reference><Citation>Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., &#x2026; Steves, C. J. (2021). Attributes and predictors of long COVID. Nature Medicine, 27(4), 626&#x2013;631. doi:10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taub, E., &amp; McKay, S. (2020). Improving thinking in everyday life: Pilot study C. Retrieved from https://ClinicalTrials.gov/show/NCT04644172.</Citation></Reference><Reference><Citation>Torous, J., J&#xe4;n Myrick, K., Rauseo-Ricupero, N., &amp; Firth, J. (2020). Digital mental health and COVID-19: Using technology today to accelerate the curve on access and quality tomorrow. Journal of Medical Internet Research, 7(3), e18848. doi:10.2196/18848.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/18848</ArticleId><ArticleId IdType="pmc">PMC7101061</ArticleId><ArticleId IdType="pubmed">32213476</ArticleId></ArticleIdList></Reference><Reference><Citation>Vannorsdall, T., &amp; Oh, E. S. (2021). Post-acute cognitive and mental health outcomes amongst COVID-19 survivors: Early findings and a call for further investigation. Journal of Internal Medicine, 290(3), 752&#x2013;754. doi:10.1111/joim.13271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13271</ArticleId><ArticleId IdType="pmc">PMC8251291</ArticleId><ArticleId IdType="pubmed">33713509</ArticleId></ArticleIdList></Reference><Reference><Citation>Veritas Health Innovation. (2021). Covidence systematic review software. Melbourne, Australia. Retrieved from www.covidence.org.</Citation></Reference><Reference><Citation>Wheatley, C. M., &amp; Shea, M. (2021). Covid-19 virtual recovery study. Retrieved from https://ClinicalTrials.gov/show/NCT04950725.</Citation></Reference><Reference><Citation>Wong, T. L., &amp; Weitzer, D. J. (2021). Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas, Lithuania), 57(5), 1&#x2013;14. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, A., Wang, J., &amp; Fullmer, N. (2022). Multimodal investigation of post COVID-19 in females: A pilot study. Retrieved from https://clinicaltrials.gov/show/NCT05225220.</Citation></Reference><Reference><Citation>Zilberman-Itskovich, S. (2020). Hyperbaric oxygen therapy for post-COVID-19 syndrome: A prospective, randomized, double blind study. Retrieved from https://clinicaltrials.gov/show/NCT04647656.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>